First genetic marker for MS severity discovered

FHS
June 28, 2023
6:10 pm

Scientists identify the first genetic marker for MS severity, opening the door to preventing long-term disability.

After the Lykos debacle, what’s next for psychedelic therapies? – Pharmaceutical Technology

The latest attempt at FDA approval for MDMA has failed, but those working with psychedelics maintain confidence that the therapy will ultimately see success. Image:

September 16, 2024

Could microalgae be the secret weapon to ending global hunger and saving the planet?

Researchers highlight the potential of commercially farmed microalgae to combat global undernutrition by providing essential nutrients and reducing environmental impacts.

September 26, 2024

Sanofi says it has 12 blockbusters in its back pocket. Will investors believe it?

NEW YORK — The top executives at French drug giant Sanofi on Wednesday defended their decision to reduce earnings forecasts for 2024 in order to

December 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.